OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety and Tolerability of Once Versus Twice Daily Atomoxetine in Adults with ADHD

HTML

Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Clinical Psychiatry
DOI: 10.1080/10401230600614603
Authors: Lenard Adler, Anthony Dietrich, Fred W. Reimherr, Leslie V. M. Taylor, Virginia K. Sutton, Rosalie Bakken, Albert J. Allen, Douglas Kelsey
Institutions: New York University, University of Utah, University of Utah Health Care, Dean Foundation, Eli Lilly (United States)
Language: English

Topic: Attention Deficit Hyperactivity Disorder
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: adult ADHD, atomoxetine, once-daily dosing, twice-daily dosing, dosing regimen, treatment-emergent adverse events, drug safety and tolerability, nausea, erectile dysfunction, insomnia, xerostomia
SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company
OpenAlex ID: W1979919601
FWCI: 3.806
Cites: 9
Cited by: 54
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security